An advisory panel to the FDA voted to recommend the agency approve the sale of a knockoff version of J&J’s arthritis drug Remicade, which had U.S. sales of $4.45 billion last year. The copy was developed by Celltrion and licensed to Pfizer.
At the start of 2016, Americans were bracing for interest rates to rise significantly for the first time since the financial crisis. Instead, rates have slumped anew, rattling financial markets and undoing the plans of investors, consumers and businesses alike.
U.S. air-safety regulators, accident investigators and pilot-union leaders issued separate warnings about the hazards of shipping lithium batteries as air cargo, boosting momentum for further international action.